Observational Study for the Evaluation of the Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV Reservoir

Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation

NCT04720742 ·Status: WITHDRAWN ·Phase: PHASE2

Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002

NCT02118168 ·Status: COMPLETED

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

NCT03041012 ·Status: COMPLETED ·Phase: PHASE2

A Long-term Follow-up of the HIV-NAT Cohort

NCT00411983 ·Status: RECRUITING

A Roll-over Observational Study for the Extended Follow-up of the Volunteers of the ISS T-003 Trial

NCT02712489 ·Status: COMPLETED

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

NCT00562510 ·Status: TERMINATED ·Phase: PHASE3

Dolutegravir in Reservoirs

NCT02924389 ·Status: TERMINATED ·Phase: PHASE4

Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation

NCT02557997 ·Status: UNKNOWN

Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

NCT02269917 ·Status: COMPLETED ·Phase: PHASE3

Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

NCT02097381 ·Status: UNKNOWN ·Phase: NA

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

NCT00807443 ·Status: COMPLETED ·Phase: PHASE2

Extended Follow-Up of the ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)

NCT05680948 ·Status: COMPLETED

Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART

NCT05584397 ·Status: ENROLLING_BY_INVITATION

Analytic Treatment Interruption (ATI) to Assess HIV Cure

NCT02437526 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

NCT01266902 ·Status: COMPLETED ·Phase: PHASE3

Post Analytic Treatment Interruption Study

NCT02761200 ·Status: RECRUITING

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

NCT00709397 ·Status: TERMINATED

Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed Viremia

NCT03198325 ·Status: COMPLETED ·Phase: NA

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

NCT02926456 ·Status: COMPLETED

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

NCT00976404 ·Status: COMPLETED ·Phase: PHASE2

Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD

NCT04311944 ·Status: UNKNOWN ·Phase: NA

A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells

NCT01173510 ·Status: WITHDRAWN ·Phase: PHASE4

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

NCT00460746 ·Status: COMPLETED ·Phase: PHASE3

Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1

NCT00795444 ·Status: COMPLETED ·Phase: PHASE2

Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure

NCT02961829 ·Status: COMPLETED ·Phase: NA